Lotus Eye Hospital & Institute Ltd (LOTUSEYE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 959118, "name": "Lotus Eye Hospit", "stock_name": "Lotus Eye Hospit", "full_name": "Lotus Eye Hospital & Institute Ltd", "name_url": "stocks-analysis/lotus-eye-hospit", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "115.50", "chg": 2.85, "chgp": "2.53%", "dir": 1, "prev_price": "112.65", "mcapval": "241.00 Cr", "mcap": "Micro Cap", "scripcode": 532998, "symbol": "LOTUSEYE", "ind_name": "Hospital", "ind_code": 94, "sector_id": 38, "indexname": "India SENSEX", "isin": "INE947I01017", "curr_date": "Sep 21, 03:30 PM", "curr_time": "18:39 PM", "last_traded_at": "Sep 21, 03:30 PM IST", "bse_nse_vol": "8.24 k", "exc_status": "Active", "traded_date": "Sep 21, 2026", "traded_date_str": "2026 09 21", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lotus-eye-hospit-959118-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Lotus Eye Hospital Declines 0.53% Amid Valuation and Technical Pressures", "link": "https://www.marketsmojo.com/news/stocks-in-action/lotus-eye-hospital-declines-053-amid-valuation-and-technical-pressures-4198236", "imagepath": "", "date": "2026-09-19 14:01:48", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>15 Sep:</strong> Valuation shifts signal heightened price risk</p>\n <p><strong>17 Sep:</strong> Death Cross formation indicates bearish trend</p>\n <p><strong>18 Sep:</strong> Downgrade to Strong Sell amid valuation and technical concerns</p>\n <p><strong>Week Close (18 Sep):</strong> Rs.112.65 (-0.53%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.113.25</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.112.65</div><div class=..." }, { "title": "Lotus Eye Hospital & Institute Ltd Downgraded to Strong Sell Amid Valuation and Technical Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/lotus-eye-hospital-institute-ltd-downgraded-to-strong-sell-amid-valuation-and-technical-concerns-4196869", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/LotusEyeHospita_mojoScore_4196869.png", "date": "2026-09-18 08:16:17", "description": "Lotus Eye Hospital & Institute Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 17 Sep 2026, driven primarily by deteriorating technical indicators and an expensive valuation profile. Despite some positive quarterly financial results, the company’s long-term fundamentals and market positioning have raised concerns among analysts, prompting a reassessment of its outlook." }, { "title": "Lotus Eye Hospital & Institute Ltd Forms Death Cross Signalling Bearish Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/lotus-eye-hospital-institute-ltd-forms-death-cross-signalling-bearish-trend-4196587", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/LotusEyeHospita_dealthcross_4196587.png", "date": "2026-09-17 18:00:40", "description": "Lotus Eye Hospital & Institute Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting a deterioration in the stock’s medium to long-term momentum and raising concerns about sustained weakness ahead." }, { "title": "Lotus Eye Hospital & Institute Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/lotus-eye-hospital-institute-ltd-is-rated-sell-4195125", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/LotusEyeHospita_mojoScore_4195125.png", "date": "2026-09-16 10:10:03", "description": "Lotus Eye Hospital & Institute Ltd is rated Sell by MarketsMOJO. This rating was last updated on 05 June 2026, reflecting a shift from a previous Strong Sell grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 16 September 2026, providing investors with an up-to-date view of its performance and outlook." }, { "title": "Lotus Eye Hospital & Institute Ltd: Valuation Shifts Signal Heightened Price Risk", "link": "https://www.marketsmojo.com/news/stocks-in-action/lotus-eye-hospital-institute-ltd-valuation-shifts-signal-heightened-price-risk-4192667", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/LotusEyeHospita_valuationdot_4192667.png", "date": "2026-09-15 08:00:57", "description": "Lotus Eye Hospital & Institute Ltd has witnessed a marked shift in its valuation parameters, moving from an already expensive rating to a very expensive classification. With a staggering price-to-earnings (P/E) ratio of 1471.99 and a price-to-book value (P/BV) of 3.92, the stock’s price attractiveness has deteriorated significantly compared to its historical averages and peer group benchmarks, raising concerns for investors amid mixed operational metrics." }, { "title": "Lotus Eye Hospital & Institute Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/lotus-eye-hospital-institute-ltd-is-rated-sell-4183260", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/LotusEyeHospita_mojoScore_4183260.png", "date": "2026-09-05 10:10:04", "description": "Lotus Eye Hospital & Institute Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 September 2026, providing investors with an up-to-date perspective on the company’s performance and outlook." }, { "title": "Lotus Eye Hospital & Institute Ltd: Valuation Shifts Signal Price Attractiveness Change", "link": "https://www.marketsmojo.com/news/stocks-in-action/lotus-eye-hospital-institute-ltd-valuation-shifts-signal-price-attractiveness-change-4180223", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/LotusEyeHospita_valuationdot_4180223.png", "date": "2026-09-03 08:01:21", "description": "Lotus Eye Hospital & Institute Ltd has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. Despite a marginal day change of 0.05%, the stock’s price-to-earnings (P/E) ratio has surged to an extraordinary 1417.4, raising questions about its price attractiveness relative to historical and peer benchmarks. This article analyses the implications of these valuation changes and what they mean for investors navigating the hospital sector." }, { "title": "Lotus Eye Hospital & Institute Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/lotus-eye-hospital-institute-ltd-is-rated-sell-4168735", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LotusEyeHospita_mojoScore_4168735.png", "date": "2026-08-25 10:10:04", "description": "Lotus Eye Hospital & Institute Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 05 June 2026, reflecting a shift from a previous 'Strong Sell' stance. However, the analysis and financial metrics discussed here represent the stock's current position as of 25 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Lotus Eye Hospital & Institute Ltd: Valuation Shifts Signal Heightened Price Risk", "link": "https://www.marketsmojo.com/news/stocks-in-action/lotus-eye-hospital-institute-ltd-valuation-shifts-signal-heightened-price-risk-4168228", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LotusEyeHospita_valuationdot_4168228.png", "date": "2026-08-25 08:01:30", "description": "Lotus Eye Hospital & Institute Ltd has seen a significant shift in its valuation parameters, moving from an already expensive rating to a very expensive classification. Despite this, the stock’s returns over various time frames have been mixed, with some periods outperforming the Sensex while others lag behind. This article analyses the recent valuation changes, compares key financial metrics with peers, and assesses the implications for investors." } ], "total": 205, "sid": "959118", "stock_news_url": "https://www.marketsmojo.com/news/lotus-eye-hospital-institute-959118" }, "announcements": [ { "caption": "Reg. 34 (1) Annual Report.", "datetime": "01-Sep-2026", "details": "Annual Report for the financial year 2025-26", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "01-Sep-2026", "details": "Newspaper Advertisements published for 29th Annual General Meeting of the Company and Annual Report for the financial year 2025-26.", "source": "BSE" }, { "caption": "29Th Annual General Meeting Of The Company - September 23 2026", "datetime": "01-Sep-2026", "details": "AGM Notice", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Lotus Eye Hospital & Institute Ltd has declared <strong>5%</strong> dividend, ex-date: 18 Sep 23", "dt": "2023-09-18", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

15 Sep: Valuation shifts signal heightened price risk

17 Sep: Death Cross formation indicates bearish trend

18 Sep: Downgrade to Strong Sell amid valuation and technical concerns

Week Close (18 Sep): Rs.112.65 (-0.53%)

Read full news article

Lotus Eye Hospital & Institute Ltd Downgraded to Strong Sell Amid Valuation and Technical Concerns

2026-09-18 08:16:17

Lotus Eye Hospital & Institute Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 17 Sep 2026, driven primarily by deteriorating technical indicators and an expensive valuation profile. Despite some positive quarterly financial results, the company’s long-term fundamentals and market positioning have raised concerns among analysts, prompting a reassessment of its outlook.

Read full news article

Lotus Eye Hospital & Institute Ltd Forms Death Cross Signalling Bearish Trend

2026-09-17 18:00:40

Lotus Eye Hospital & Institute Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting a deterioration in the stock’s medium to long-term momentum and raising concerns about sustained weakness ahead.

Read full news article

Lotus Eye Hospital & Institute Ltd is Rated Sell

2026-09-16 10:10:03

Lotus Eye Hospital & Institute Ltd is rated Sell by MarketsMOJO. This rating was last updated on 05 June 2026, reflecting a shift from a previous Strong Sell grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 16 September 2026, providing investors with an up-to-date view of its performance and outlook.

Read full news article

Lotus Eye Hospital & Institute Ltd: Valuation Shifts Signal Heightened Price Risk

2026-09-15 08:00:57

Lotus Eye Hospital & Institute Ltd has witnessed a marked shift in its valuation parameters, moving from an already expensive rating to a very expensive classification. With a staggering price-to-earnings (P/E) ratio of 1471.99 and a price-to-book value (P/BV) of 3.92, the stock’s price attractiveness has deteriorated significantly compared to its historical averages and peer group benchmarks, raising concerns for investors amid mixed operational metrics.

Read full news article

Lotus Eye Hospital & Institute Ltd is Rated Sell

2026-09-05 10:10:04

Lotus Eye Hospital & Institute Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 September 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Lotus Eye Hospital & Institute Ltd: Valuation Shifts Signal Price Attractiveness Change

2026-09-03 08:01:21

Lotus Eye Hospital & Institute Ltd has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. Despite a marginal day change of 0.05%, the stock’s price-to-earnings (P/E) ratio has surged to an extraordinary 1417.4, raising questions about its price attractiveness relative to historical and peer benchmarks. This article analyses the implications of these valuation changes and what they mean for investors navigating the hospital sector.

Read full news article

Lotus Eye Hospital & Institute Ltd is Rated Sell

2026-08-25 10:10:04

Lotus Eye Hospital & Institute Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 05 June 2026, reflecting a shift from a previous 'Strong Sell' stance. However, the analysis and financial metrics discussed here represent the stock's current position as of 25 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Lotus Eye Hospital & Institute Ltd: Valuation Shifts Signal Heightened Price Risk

2026-08-25 08:01:30

Lotus Eye Hospital & Institute Ltd has seen a significant shift in its valuation parameters, moving from an already expensive rating to a very expensive classification. Despite this, the stock’s returns over various time frames have been mixed, with some periods outperforming the Sensex while others lag behind. This article analyses the recent valuation changes, compares key financial metrics with peers, and assesses the implications for investors.

Read full news article